Ivan Milanov

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 424 citations

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial

Gregory L. Krauss, Pavel Klein, Christian Brandt et al. · The Lancet Neurology · 2019 · 317 citations

Uncontrolled Focal Seizures, Adjunctive Cenobamate, Neurological Monitoring +4

Abnormal Modulatory Influence of Diffuse Noxious Inhibitory Controls in Migraine and Chronic Tension-Type Headache Patients

Giorgio Sandrini, Paolo Rossi, Ivan Milanov et al. · Cephalalgia · 2006 · 273 citations

Cluster Headache, Pain Syndrome, Abnormal Modulatory Influence +15

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Angelo Antonini, Werner Poewe, К. Ray Chaudhuri et al. · Parkinsonism & Related Disorders · 2017 · 206 citations · Full text